van den Bosch J F, Kanis I Y, Antonissen A C, Buurman W A, van Boven C P
Infect Immun. 1986 Sep;53(3):611-5. doi: 10.1128/iai.53.3.611-615.1986.
Purified rRNA from Listeria monocytogenes or Pseudomonas aeruginosa injected in combination with dimethyldioctadecylammonium bromide (DDA), protects mice nonspecifically against a lethal challenge of various extra- and intracellular bacteria. In the present study vaccination of BALB/c as well as C57BL/Ka mice with listerial RNA-DDA resulted in activation of fixed-tissue macrophages, as measured by an enhanced in vivo L. monocytogenes killing in spleen and liver. Evidence was found that macrophage activation by vaccination with rRNA-DDA occurred by a T-cell-independent mechanism. Treatment of mice with cyclosporin A had no effect on the enhanced L. monocytogenes killing induced with RNA-DDA; in vitro exposure of RNA-DDA to spleen cell cultures did not give rise to any lymphocyte proliferation. No evidence could be found for a possible adjuvant activity for RNA-DDA in cellular responses; in fact, RNA-DDA had an inhibitory effect on lymphocyte proliferative responses to Listeria antigen and to concanavalin A.
将来自单核细胞增生李斯特菌或铜绿假单胞菌的纯化rRNA与二甲基二十八烷基溴化铵(DDA)联合注射,可非特异性地保护小鼠免受各种胞外和胞内细菌的致死性攻击。在本研究中,用李斯特菌RNA-DDA对BALB/c以及C57BL/Ka小鼠进行疫苗接种,可导致固定组织巨噬细胞的激活,这通过脾脏和肝脏中体内单核细胞增生李斯特菌杀伤能力增强来衡量。有证据表明,用rRNA-DDA进行疫苗接种激活巨噬细胞是通过非T细胞依赖机制发生的。用环孢素A处理小鼠对RNA-DDA诱导的单核细胞增生李斯特菌杀伤增强没有影响;RNA-DDA在体外与脾细胞培养物接触不会引起任何淋巴细胞增殖。未发现RNA-DDA在细胞反应中可能具有佐剂活性的证据;事实上,RNA-DDA对淋巴细胞对李斯特菌抗原和刀豆球蛋白A的增殖反应具有抑制作用。